(Q51059095)

27 March 2018

title

Can local radiotherapy and IL-12 synergise to overcome the immunosuppressive tumor microenvironment and allow "in situ tumor vaccination"? (English)

1 reference

27 March 2018

author name string

Gaël Deplanque

series ordinal

1

1 reference

27 March 2018

Keyvan Shabafrouz

series ordinal

2

1 reference

27 March 2018

Michel Obeid

series ordinal

3

1 reference

27 March 2018

publication date

13 April 2017

1 reference

27 March 2018

Cancer Immunology, Immunotherapy

published in

1 reference

27 March 2018

volume

66

1 reference

27 March 2018

issue

7

1 reference

27 March 2018

page(s)

833-840

1 reference

27 March 2018

Inflammation and cancer revisited: an hypothesis on the oncogenic potential of the apoptotic tumor cell.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Role of Local Radiation Therapy in Cancer Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Combination effect of regulatory T-cell depletion and ionizing radiation in mouse models of lung and colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

The abscopal effect and chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Immunologic correlates of the abscopal effect in a patient with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Local radiation therapy inhibits tumor growth through the generation of tumor-specific CTL: its potentiation by combination with Th1 cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Interleukin-12 in anti-tumor immunity and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell-mediated glioma rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-2000-4

10.1007/S00262-017-2000-4

21 January 2018

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018